Insider Transactions in Q1 2023 at Acelrx Pharmaceuticals Inc (ACRX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
398
-2.08%
|
$398
$1.31 P/Share
|
|
Mar 03
2023
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,703
-2.6%
|
$1,703
$1.31 P/Share
|
|
Mar 03
2023
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-2.26%
|
$510
$1.31 P/Share
|
|
Mar 03
2023
|
Pamela P Palmer Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
570
-1.3%
|
$570
$1.31 P/Share
|
|
Feb 11
2023
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
873
-3.72%
|
$873
$1.68 P/Share
|
|
Feb 11
2023
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
776
-3.89%
|
$776
$1.68 P/Share
|
|
Feb 11
2023
|
Pamela P Palmer Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,017
-2.26%
|
$1,017
$1.68 P/Share
|
|
Feb 11
2023
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,321
-4.82%
|
$3,321
$1.68 P/Share
|
|
Feb 10
2023
|
Raffi Asadorian Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,875
+20.02%
|
-
|
|
Feb 10
2023
|
Badri N Dasu Chief Engineering Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+19.64%
|
-
|
|
Feb 10
2023
|
Pamela P Palmer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,125
+12.0%
|
-
|
|
Feb 10
2023
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+22.07%
|
-
|
|
Feb 06
2023
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
458
-2.95%
|
$916
$2.02 P/Share
|
|
Feb 06
2023
|
Pamela P Palmer Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-1.73%
|
$1,362
$2.02 P/Share
|
|
Feb 06
2023
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
617
-3.39%
|
$1,234
$2.02 P/Share
|
|
Feb 06
2023
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,982
-3.86%
|
$3,964
$2.02 P/Share
|